Notably, overexpression of Par-4 itself increased senescence in glioma cells, whereas, shRNA- or siRNA-mediated inhibition of Par-4 significantly negated the thymoquinone-induced senescence, hence, underscoring the prime role of Par-4. Here, PAWR is linked to central nervous system cancer.